Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.

June 9, 2020
Open Access

Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective

Cytometry. Part a : the Journal of the International Society for Analytical Cytology
Henning UlrichAttila Tárnok
June 12, 2020

Antibody-dependent enhancement and COVID-19: Moving toward acquittal

Clinical Immunology : the Official Journal of the Clinical Immunology Society
Eric J Yager
April 9, 2020
Open Access

Defeat Dengue and Zika Viruses With a One-Two Punch of Vaccine and Vector Blockade

Frontiers in Microbiology
Jin SunXia Jin
April 1, 2020
Open Access

Impact of glycan positioning on HIV-1 Env glycan shield density, function, and antibody recognition

BioRxiv : the Preprint Server for Biology
Qing WeiJan Novak
April 28, 2020

Focus on Receptors for Coronaviruses with Special Reference to Angiotensin-converting Enzyme 2 as a Potential Drug Target - A Perspective

Endocrine, Metabolic & Immune Disorders Drug Targets
Thea MagroneEmilio Jirillo
April 9, 2020

Dengue hemorrhagic fever - A systemic literature review of current perspectives on pathogenesis, prevention and control

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
Wen-Hung WangSheng-Fan Wang
June 14, 2020
Open Access

Hypothesis to explain the severe form of COVID-19 in Northern Italy

BMJ Global Health
Luca CegolonGiuseppe Pichierri
June 6, 2020

Japanese encephalitis virus-primed CD8+ T cells prevent antibody-dependent enhancement of Zika virus pathogenesis

The Journal of Experimental Medicine
Dong ChenJinsheng Wen
June 6, 2020
Open Access

Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)

Journal of Biomedical Science
Feng-Yee ChangHuey-Kang Sytwu
February 7, 2020
Open Access

A Review on Dengue Vaccine Development

Sheng-Qun DengHong-Juan Peng
April 30, 2020

Strategies for vaccine development of COVID-19

Sheng wu gong cheng xue bao = Chinese journal of biotechnology
Limin YangWenjun Liu
April 24, 2020
Open Access

Patients with breakthrough tick-borne encephalitis suffer a more severe clinical course and display extensive MRI changes

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Judith N WagnerTim J von Oertzen

Sign up to follow this feed and discover related papers.

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Antibody Development

Development of antibodies require integration of knowledge with respect to target antigen properties, antibody design criteria such as affinity, isotype selection, Fc domain engineering, and antibody cross-reactivity across species from the early stages of antibody development. Here is the latest research.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antibody synthesis

Antibodies have various functions including neutralization of pathogens, tumor targeting, as well as its utility in biomedical research. Here is the latest research on antibody synthesis.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

B cell Tolerance

B cell tolerance is maintained through mechanisms that can reversibly or irreversibly silence autoreactive B lymphocytes. Here is the latest research.

© 2020 Meta ULC. All rights reserved